First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817 - Concepedia

Concepedia

Publication | Open Access

First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817

DOI Full Paper Access

67

Citations

37

References

2023

Year

Neal Ready, Clarisse Audigier-Valette, Jonathan W. Goldman, Enriqueta Felip, Tudor–Eliade Ciuleanu, M.R. García Campelo, Kevin Jao, Fabrice Barlési, Stéphanie Bordenave-Juchereau, Erika Rijavec,

Journal for ImmunoTherapy of Cancer

Abstract

NCT02869789.

References

	Year	Citations

Page 1